Acknowledgement

This activity is provided by Talem Health and RME Collaborative.
     
In collaboration with the Southeast AIDS Education & Training Center.

This activity is supported by an independent educational grant from Gilead Sciences, Inc.

Credit Available

• Physicians — maximum of 1.5 AMA PRA Category 1 Credits™
• Nurses — 1.5 Contact Hours (1.0 contact hour of pharmacotherapy credit)
• Pharmacists — 1.5 Contact Hours

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed specifically for primary care clinicians, nurses, pharmacists, and other members of the healthcare team who serve patients in rural and underserved communities. 

Program Overview

The Ending the HIV Epidemic (EHE) initiative is an ongoing federal effort to reduce the number of new HIV infections in the US by at least 90% by 2030 through four implementation pillars: diagnose, treat, prevent, and respond. Thus, addressing health inequities and disparities in care and viral suppression in rural and underserved communities remains critical. In this activity, expert faculty will provide a comprehensive overview of HIV treatment approaches, current guideline recommendations and clinical trial evidence, and interventions to optimize the care continuum in rural and underserved communities. Team-based approaches to support continued access and engagement in care will also be discussed.

This activity is a recording from a webinar series that took place in October 2023. Please note that any data, information, and guidance presented in the activity are subject to change.

Learning Objectives

Upon completion of this activity, participants should be better able to: 

• Evaluate HIV therapies based on their efficacy, safety, adherence potential, and drug-drug interactions
• Apply current recommendations, clinical evidence, and patient characteristics into treatment selection for patients with HIV 
• Utilize interprofessional strategies for optimizing HIV management, reducing stigma, and engaging rural and underserved populations in care and treatment 

Faculty

Paul E. Sax, MD
Clinical Director, Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Boston, MA


Cody A. Chastain, MD, FACP, FIDSA
Principal Investigator, Southeast AIDS Education and Training Center
Vanderbilt University Medical Center
Assistant Professor of Medicine
Assistant Dean, Undergraduate Medical Education Program Evaluation and Improvement
Vanderbilt University School of Medicine
Nashville, TN

Joint Accreditation Statement

In support of improving patient care, Talem Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement

Physician Continuing Medical Education
Talem Health designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours. Designated for 1.0 contact hour of pharmacotherapy credit for Advanced Practice Registered Nurses.

Continuing Pharmacy Education
Talem Health designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – JA4008332-0000-24-001-H02-P)
Type of Activity: Application

For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service.

Disclosure of Conflicts of Interest

Talem Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All identified conflicts of interest are thoroughly vetted and mitigated according to Talem Health policy. Talem Health is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

All relevant financial relationships have been mitigated.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Faculty

Paul E. Sax, MD, has disclosed the following relevant financial relationships: scientific advisory board member/consultant for Gilead Sciences, Inc., GlaxoSmithKline/ViiV Healthcare, Janssen Pharmaceuticals, and Merck & Co., Inc.; research support from Gilead Sciences, Inc. and GlaxoSmithKline/ViiV Healthcare.

Cody A. Chastain, MD, FACP, FIDSA, has no relevant financial relationships to disclose.

Planners, Managers, and Reviewer

The Talem Health and RME Collaborative planners, managers, and reviewer have nothing to disclose.

Instructions for Participation and Credit

This activity is offered at no cost to participants. To receive CME credit, participants must:

1. Read the CME/CE information, including learning objectives and disclosure statements.
2. Complete the pre-test.
3. View the online activity.
4. Complete the post-test and evaluation form.

A post-test score of 75% or higher is required to obtain credit. Your certificate will be made available for immediate download.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

©RME Collaborative, a division of Talem Health, LLC. All Rights Reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Talem Health, LLC is prohibited.

Media

Internet activity

Fee Information

There is no fee for this educational activity.

Contact Information

General Questions
For questions about this activity, please contact RME Collaborative (a division of Talem Health) at 800-913-9370 or cme@cmeruralhealth.com.